Respiratory Syncytial Virus Vaccines
"Respiratory Syncytial Virus Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent infection with RESPIRATORY SYNCYTIAL VIRUSES.
| Descriptor ID |
D022261
|
| MeSH Number(s) |
D20.215.894.899.730
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Respiratory Syncytial Virus Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Respiratory Syncytial Virus Vaccines".
This graph shows the total number of publications written about "Respiratory Syncytial Virus Vaccines" by people in this website by year, and whether "Respiratory Syncytial Virus Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 12 | 2 | 14 |
| 2018 | 11 | 4 | 15 |
| 2019 | 8 | 1 | 9 |
| 2020 | 2 | 2 | 4 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Respiratory Syncytial Virus Vaccines" by people in Profiles.
-
Infectious disease mRNA vaccines and a review on epitope prediction for vaccine design. Brief Funct Genomics. 2021 09 11; 20(5):289-303.
-
RSV genomic diversity and the development of a globally effective RSV intervention. Vaccine. 2021 05 18; 39(21):2811-2820.
-
Autophagy in T cells from aged donors is maintained by spermidine and correlates with function and vaccine responses. Elife. 2020 12 15; 9.
-
What Does Severe Acute Respiratory Syndrome Coronavirus 2 Mean for Global Pneumonia Prevention, Diagnosis, and Treatment? Chest. 2021 02; 159(2):486-488.
-
Learning from the past: development of safe and effective COVID-19 vaccines. Nat Rev Microbiol. 2021 03; 19(3):211-219.
-
First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults. Clin Infect Dis. 2020 05 06; 70(10):2073-2081.
-
Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants. J Infect Dis. 2019 10 22; 220(11):1802-1815.
-
Association of Age at First Severe Respiratory Syncytial Virus Disease With Subsequent Risk of Severe Asthma: A Population-Based Cohort Study. J Infect Dis. 2019 07 19; 220(4):550-556.
-
Evaluation of the role of respiratory syncytial virus surface glycoproteins F and G on viral stability and replication: implications for future vaccine design. J Gen Virol. 2019 07; 100(7):1112-1122.
-
Chitosan alters inactivated respiratory syncytial virus vaccine elicited immune responses without affecting lung histopathology in mice. Vaccine. 2019 07 09; 37(30):4031-4039.